**Core Concept**
The question tests the association between a specific set of clinical manifestations (diabetes mellitus, gallstones, and steatorrhea) and a particular type of tumor. This association is rooted in the pathophysiological consequences of a neoplastic process affecting the pancreas.

**Why the Correct Answer is Right**
The correct answer is associated with a tumor that affects the pancreas, leading to diabetes mellitus (due to loss of insulin-producing beta cells), gallstones (due to increased concentration of bile salts and cholesterol in the gallbladder), and steatorrhea (due to malabsorption of fats in the small intestine). The tumor in question produces excessive amounts of somatostatin, a hormone that inhibits the secretion of pancreatic enzymes and hormones, including insulin and glucagon.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the tumor associated with the triad of diabetes mellitus, gallstones, and steatorrhea is not a type of carcinoid tumor, which is typically associated with a different set of clinical manifestations.
* **Option B:** This option is incorrect because the tumor associated with the triad of diabetes mellitus, gallstones, and steatorrhea is not a type of pancreatic adenocarcinoma, which is typically associated with a more aggressive clinical course and different clinical manifestations.
* **Option D:** This option is incorrect because the tumor associated with the triad of diabetes mellitus, gallstones, and steatorrhea is not a type of gastrinoma, which is typically associated with peptic ulcers and diarrhea.

**Clinical Pearl / High-Yield Fact**
The tumor associated with the triad of diabetes mellitus, gallstones, and steatorrhea is often referred to as a "somatostatinoma," and it is a rare type of pancreatic tumor that can be challenging to diagnose and treat.

**Correct Answer:** C. Somatostatinoma.